首页> 外国专利> METHODS AND COMPOSITIONS RELATING TO HEMATOLOGIC MALIGNANCIES

METHODS AND COMPOSITIONS RELATING TO HEMATOLOGIC MALIGNANCIES

机译:与血液学异常有关的方法和成分

摘要

Methods of treating a subject having, or at risk of having, a myeloproliferative disorder are provided according to embodiments of the present invention which include administering a therapeutically effective amount of an arachidonate 5-lipoxygenase (5-LO) inhibitor to the subject. Combinations of therapeutic agents are administered according to embodiments of the present invention. In some embodiments, two or more 5-LO inhibitors are administered to a subject to treat a myeloproliferative disorder. In further embodiments, at least one 5-LO inhibitor and at least one additional therapeutic agent are administered to a subject to treat a myeloproliferative disorder. Methods of inhibiting leukemia stem cells are provided according to embodiments of the present invention which include contacting leukemia stem cells with an effective amount of an arachidonate 5-lipoxygenase inhibitor.
机译:根据本发明的实施方案,提供了治疗患有骨髓增生性疾病或具有患骨髓增生性疾病的受试者的方法,该方法包括向该受试者施用治疗有效量的花生四烯酸5-脂氧合酶(5-LO)抑制剂。根据本发明的实施方案施用治疗剂的组合。在一些实施方案中,将两种或更多种5-LO抑制剂给予受试者以治疗骨髓增生性疾病。在进一步的实施方案中,将至少一种5-LO抑制剂和至少一种其他治疗剂施用于受试者以治疗骨髓增生性疾病。根据本发明的实施方案,提供了抑制白血病干细胞的方法,该方法包括使白血病干细胞与有效量的花生四烯酸5-脂氧合酶抑制剂接触。

著录项

  • 公开/公告号US2012114605A1

    专利类型

  • 公开/公告日2012-05-10

    原文格式PDF

  • 申请/专利权人 SHAOGUANG LI;

    申请/专利号US201013265716

  • 发明设计人 SHAOGUANG LI;

    申请日2010-04-26

  • 分类号A61K31/65;A61K31/426;A61K31/407;A61K31/415;C12Q1/26;A61K38/21;A61P35/02;A61P35;C12N5/09;G01N33/573;A61K31/381;A61K31/12;

  • 国家 US

  • 入库时间 2022-08-21 17:29:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号